★ Sign in to follow
HN

Henrik Nittmar

Executive
Chief Executive Officer
SE·Finansinspektionen
Corline Biomedical AB
Insider activity · 24 months2 buys1 saleCumulative net flow
Total declarations
9
Company
1
▲ Purchases (6 ops.)
€125k
▼ Sales (1 ops.)
€9,436

Latest filing published 09 Oct 2026 for Corline Biomedical AB, €9,436.

Filing timeline

BuySale
Henrik Nittmar

Insider track record

Disclosed buys
6
Disclosed sells
1
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Henrik Nittmar: trading record in brief

All filings by Henrik Nittmar on record concern Corline Biomedical AB, in the capacity of chief executive. Between 22 January 2021 and 26 August 2026, the trades on record add up to 9 filings.

Both buying and selling appear: 6 purchases worth €125k, against 1 sale worth €9,436. Netting one side against the other leaves €116k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and 1 sale.

In size, the median ticket on the buying side is €18k.

The newest entry dates from 9 October 2026: an open-market sale of €9,436, in Corline Biomedical AB. The clock since the last published purchase (17 February 2026) now reads 264 days. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Henrik Nittmar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▼
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    105,133 SEK32FI-SE
    6,557 shares@ SEK 16.03370.023% mcap30.9% of flowAktieISIN SE0006887451FI:csv-2395d0453e46348ce835
  • ▲
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    145,400 SEK30FI-SE
    10,000 shares@ SEK 14.540.032% mcap100.0% of flowAktieISIN SE0006887451FI:A003W101-1
    Canonical exit: 18 May 2026 (T+90)
  • ▲
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    231,400 SEK30FI-SE
    13,000 shares@ SEK 17.800.051% mcap100.0% of flowAktieFI:A003T765-1
    Canonical exit: 16 Feb 2026 (T+90)
  • ▲
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    76,937 SEK0FI-SE
    85,963 shares@ SEK 0.8954.3% of flowTeckningsoptionFI:csv-d7934b9462ed2b6ae26c
    Canonical exit: 1 Sept 2024 (T+90)
  • ▲
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    179,395 SEK0FI-SE
    75,218 shares@ SEK 2.38510.1% of flowTeckningsoptionFI:csv-13413002a9b8869fb467
    Canonical exit: 2 Aug 2023 (T+90)
  • ●
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    89,209 SEK0FI-SE
    75,218 shares@ SEK 1.1865.0% of flowTeckningsoptionFI:csv-128528deabc1d09725da
  • ●
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    18,525 SEK0FI-SE
    42,982 shares@ SEK 0.4311.1% of flowTeckningsoptionFI:csv-9d84cd4d8e4464e8afad
  • ▲
    Henrik Nittmar
    Verkställande direktör (VD)ExecutivesCorline Biomedical AB
    468,320 SEK0FI-SE
    46,832 shares@ SEK 10.0051.3% of flowBTA (betald tecknad aktie)FI:csv-497ac4cb945ea3a7bc69
    Canonical exit: 22 Apr 2021 (T+90)

8 of 8 declarations

Related entities

No related entities found.